89 related articles for article (PubMed ID: 8754418)
1. [Hepatitis C following administration of intravenous immunoglobulins].
Cabrera Chaves T; Simón Marco MA; Gomollón García F; Botella Esteban MT; Uribarrena Echebarría R
Gastroenterol Hepatol; 1996; 19(6):305-8. PubMed ID: 8754418
[TBL] [Abstract][Full Text] [Related]
2. Outbreak of hepatitis C associated with intravenous immunoglobulin administration--United States, October 1993-June 1994.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1994 Jul; 43(28):505-9. PubMed ID: 8022396
[TBL] [Abstract][Full Text] [Related]
3. Outcome of intravenous immunoglobulin-transmitted hepatitis C virus infection in primary immunodeficiency.
Razvi S; Schneider L; Jonas MM; Cunningham-Rundles C
Clin Immunol; 2001 Dec; 101(3):284-8. PubMed ID: 11726220
[TBL] [Abstract][Full Text] [Related]
4. Follow-up of four HIV-infected individuals after administration of hepatitis C virus and GBV-C/hepatitis G virus contaminated intravenous immunoglobulin: evidence for HCV but not for GBV-C/HGV transmission.
Berger A; Doerr HW; Scharrer I; Weber B
J Med Virol; 1997 Sep; 53(1):25-30. PubMed ID: 9298728
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C and immune globulin.
López-Jiménez J; Odriozola J; Pérez-Oteyza J; García-Laraña J
N Engl J Med; 1995 May; 332(18):1235-6. PubMed ID: 7700324
[No Abstract] [Full Text] [Related]
6. [Study on the epidemiology and distribution of human immunodeficiency virus-1 and hepatitis C virus infection among intravenous drug users and illegal blood donors in China].
Yin N; Mei S; Li L; Wei FL; Zhang LQ; Cao YZ
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov; 24(11):962-5. PubMed ID: 14687492
[TBL] [Abstract][Full Text] [Related]
7. [Epidemiological information obtained from anti-hepatitis C virus screening in blood donors and candidates for autologous transfusion from 1992 to 1996 in the Alpes-Maritimes region].
Ouzan D; Pesle B; Baldini E; Rimbourg H; Darphin F; Cohen N; Brichetti A; Follana R
Gastroenterol Clin Biol; 2000 Mar; 24(3):337-41. PubMed ID: 10804343
[TBL] [Abstract][Full Text] [Related]
8. 111 cases of hepatitis C linked to Gammagard. Patient screening recommended.
Am J Hosp Pharm; 1994 Oct; 51(19):2326. PubMed ID: 7847397
[No Abstract] [Full Text] [Related]
9. [Laboratory markers in hepatitis C virus infection in patients with antibody formation disorders treated with immunoglobulin preparations].
Litzman J; Pejcochová J; Lokaj J
Vnitr Lek; 1996 May; 42(5):324-6. PubMed ID: 8768290
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C transmission associated with intravenous immunoglobulins.
Nübling CM; Willkommen H; Löwer J
Lancet; 1995 May; 345(8958):1174. PubMed ID: 7536875
[No Abstract] [Full Text] [Related]
11. The safety of immune globulins.
Tepper M; Gully P
Can Commun Dis Rep; 1996 Jul; 22(14):117-9. PubMed ID: 8754937
[No Abstract] [Full Text] [Related]
12. Evaluation of the French national plan to promote screening and early management of viral hepatitis C, between 1997 and 2003: a comparative cross-sectional study in Poitou-Charentes region.
Defossez G; Verneau A; Ingrand I; Silvain C; Ingrand P; Beauchant M;
Eur J Gastroenterol Hepatol; 2008 May; 20(5):367-72. PubMed ID: 18403936
[TBL] [Abstract][Full Text] [Related]
13. [The problem of hepatitis C virus infection in blood donors. Clinico-epidemiological, virological and histological evaluation].
Sookoian S; Castaño G; Castiglioni T; Pilar S; Viudez P; González J; Frider B
Medicina (B Aires); 1997; 57(6):699-707. PubMed ID: 9674191
[TBL] [Abstract][Full Text] [Related]
14. From the Centers for Disease Control and Prevention. Outbreak of hepatitis C associated with intravenous immunoglobulin administration--United States, October 1993-June 1994.
JAMA; 1994 Aug; 272(6):424-5. PubMed ID: 8040966
[No Abstract] [Full Text] [Related]
15. [Epidemiology of hepatitis C virus infection in 1,304 HCV positive patients: variations according to the origin of transmission and year of diagnosis].
Guyader D; Lefeuvre C; Jacquelinet S; Prat M; Baudouard Y; Turlin B; André P; Mendler MH; Sapey T; Boucher E; Moirand R; Messner M; Colimon R; Brissot P; Deugnier Y
Gastroenterol Clin Biol; 1998 Apr; 22(4):375-80. PubMed ID: 9762266
[TBL] [Abstract][Full Text] [Related]
16. Follow-up studies of hepatitis C association with an intravenous immunoglobulin.
Yu MW
Dev Biol Stand; 1996; 88():215-6. PubMed ID: 9119139
[No Abstract] [Full Text] [Related]
17. [Screening of patients at risk for hepatitis C virus infection in general medicine].
Altman C; Lesiour A; Dunbavand A; Meyer L; de la Selle P; Buffet C
Gastroenterol Clin Biol; 1999 Mar; 23(3):359-62. PubMed ID: 10384340
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C infection presenting with rheumatic manifestations: a mimic of rheumatoid arthritis.
Lovy MR; Starkebaum G; Uberoi S
J Rheumatol; 1996 Jun; 23(6):979-83. PubMed ID: 8782126
[TBL] [Abstract][Full Text] [Related]
19. Experimental experience with virus validation studies.
Willkommen H
Dev Biol Stand; 1996; 88():317-8. PubMed ID: 9119155
[No Abstract] [Full Text] [Related]
20. Hepatitis C and immune globulin.
Prince AM; Horowitz B
N Engl J Med; 1995 May; 332(18):1236; author reply 1236-7. PubMed ID: 7700325
[No Abstract] [Full Text] [Related]
[Next] [New Search]
